PLx Pharma Inc. (PLXP)
Company Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States.
The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules.
Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever.
The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels.
PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.
| Country | United States |
| IPO Date | Mar 13, 2014 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Natasha Giordano |
Contact Details
Address: 9 Fishers Lane Sparta, New Jersey United States | |
| Website | https://plxpharma.com |
Stock Details
| Ticker Symbol | PLXP |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001497504 |
| CUSIP Number | 72942A107 |
| ISIN Number | US72942A1079 |
| Employer ID | 27-1707962 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Charles Edmund Sheedy C.F.A., CFA | Member of Chief Executive Officer Advisory Group |
| Harris Kaplan M.B.A., MBA | Member of Chief Executive Officer Advisory Group |
| Natasha Giordano | Chief Executive Officer, Pres & Director |
| Patrick M. Lonergan | Member of Chief Executive Officer Advisory Group |
| Rita M. O'Connor CPA, CPA | Chief Financial Officer and Head of Manufacturing & Supply Chain |
| Gary L. Mossman | Senior Advisor |
| Janet M. Barth | Vice President of Investor Relations & Corporation Communications |
| Joanne Cotignola | Vice President of Marketing |
| Michael J. Valentino | Executive Chairman |
| Ronald R. Zimmerman | Founder & Senior Advisor |
| Tom Long | Vice President of Manufacturing & Technical Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 18, 2023 | 15-12G | Filing |
| Sep 20, 2023 | 8-K | Current Report |
| Aug 22, 2023 | 8-K | Current Report |
| Jul 21, 2023 | 8-K | Current Report |
| Jul 12, 2023 | 8-K | Current Report |
| Jul 07, 2023 | 8-K | Current Report |
| Jun 27, 2023 | 8-K | Current Report |
| May 26, 2023 | 8-K | Current Report |
| May 02, 2023 | 25-NSE | Filing |
| Apr 13, 2023 | 8-K | Current Report |